+ All Categories
Home > Documents > Examples from Genome-wide Study Analyses - DTU Health …1/6/10 2 Individuals were taken from the...

Examples from Genome-wide Study Analyses - DTU Health …1/6/10 2 Individuals were taken from the...

Date post: 17-Feb-2021
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
8
1/6/10 1 Part 4 Examples from Genome-wide Study Analyses (Weedon, MN et al. Nat Genet. 2007) Example Human Height: GWAS fail to describe the major variation in phenotypes Human height (80-90% heritable), but.. >40 SNPs only explain ~5% variation (Commentary: Brendan Maher, Nature, 2008) Top candidate HMGA2; 0.4 cm increased height pr. copy; ~0.3% of the population’s variation (Weedon, MN et al. Nat Genet. 2007) Possible Explanations Rare variants: common disease, common variant hypothesis does not hold Submicroscopic variation (> 0.1kb & <3MB): Eg. copy number variations Epistatic effects Epigenetics New England Journal of Medicine Commentaries: D. B. Goldstein Common Genetic Variation and Human Traits. NEJM, 2009 J. N. Hirschhorn. Genomewide Association Studies — Illuminating Biologic Pathways. NEJM 2009 P. Kraft and D. J. Hunter. Genetic Risk Prediction — Are We There Yet? NEJM 2009 Science Reply: R. Koenig Genome Scans: Impatient for the Payoff. Science 2009 (The New York Times 16/4/2009)
Transcript
  • 1/6/10

    1

    Part 4

    Examples from Genome-wide Study Analyses

    (Weedon,
MN
et
al.
Nat
Genet.
2007)


    Example Human Height: GWAS fail to describe the major variation in phenotypes

    Human height (80-90% heritable), but.. –  >40 SNPs only explain ~5% variation (Commentary: Brendan Maher, Nature, 2008) –  Top candidate HMGA2; 0.4 cm increased height pr. copy; ~0.3% of the population’s variation

    (Weedon, MN et al. Nat Genet. 2007)

    Possible Explanations –  Rare variants: common disease, common variant hypothesis does not hold –  Submicroscopic variation (> 0.1kb &

  • 1/6/10

    2

    Individuals were taken from the Nugenob Weight Loss Trial

    ‘Nutrient-Gene Interactions in Human Obesity’, coordinated by Thorkild IA Sørensen, Institute of Preventive Medicine, Denmark (Sørensen, TIA et al. PLoS Clin Trials 2006)

    771 obese male and female unrelated obese European Caucasians from 8 clinical centers in seven European countries

    –  Age 20-50 years –  BMI > 29.5

    Weight Loss Trial: Randomized trial of a hypo-energetic high- versus low-fat diet –  - 600 kcal/d –  Fat energy 40-45% or 20-25% –  Same mean weight loss across diets (6.9 kg, 6.7 kg) –  In total 648 completers (More dropouts on the high-fat diet)

    Fat Oxidation Measurement: Test meal with energy content fixed at 50% at the predicted basal metabolic rate. Indirect calorimetry was used assess energy expenditure and substrate oxidation.

    750 subjects were genotyped on Illumina HumanHap 300K SNP arrays

    There is Structure among Individuals in the Nugenob Cohort

  • 1/6/10

    3

    Weight Loss Phenotype does not co-localize with Ancestry

    Fat Oxidation Phenotype does not co-localize with Ancestry

  • 1/6/10

    4

    The Regression Models in the GWAS are adjusted for various variables

    FatOxPP ~ gender + center + baseline FatOx + baseline FatOx2 + SNPi

    WL ~ gender + age + age2 + center + diet group + baseline weight + SNPi

    WLDiet ~ gender + age + age2 + center + diet group + baseline weight + SNPi + SNPi*diet group

    Abbreviations and explanations: •  FatOx; Fat oxidation capacity •  WL; Amount of kg’s lost in the 10 weak weight loss trial •  Center; Which European center the individual originates from •  Diet group; Either high fat or low fat diet

    Manhattan Plot lacks Skyscrapers above the Bonferroni Skyline Level

  • 1/6/10

    5

    Quantile-Quantile Plot shows that there is no major deviation from random expectations

    Enrichment of Effect Size, an increase of Individuals and/or Integration reduce Chance Correlations

    Challenge The human genome is so large that it is very likely to incur a large amount of chance-correlation instead of causal SNPs in the statistical analysis.

    Solutions 1.  Enrich the study cohort for the phenotype you are looking for (Increase

    the effect size of causal SNPs) 2.  Increase number of genotyped Individuals 3.  Add independent phenotype-specific data (e.g. gene expression data)

  • 1/6/10

    6

    Example on how Genetic Data may be integrated with GWAS Data

    (Hansen,
Lage,
Pers
et
al,
SubmiIed)


    Genes are scored based on the GWAS SNPs mapped to the Gene

    (Ensembl
Genome
Browser,
www.ensembl.org)


    SN

    P

    SN

    P

    SN

    P

    SN

    P

    SN

    P

    SN

    P

    Steps to score a gene 1)  GWAS: SNPi -> P-valuei 2)  Score genex with the lowest p-value of all SNPs mapped to genex 3)  Correct genex score with the number of independent number of SNPs mapped to genex

  • 1/6/10

    7

    Long Genes are more likely to harbour non-causal SNPs correlating with the Phenotype by Chance

    Gen

    e Le

    ngth

    (bp

    s)

    # SN

    Ps p

    er g

    ene

    # SN

    Ps p

    er g

    ene

    Minimum SNP in Gene Minimum SNP in Gene Gene Length (bps)

    Adjustment by independent number of SNPs per Gene corrects Gene Length Bias

    Gen

    e Le

    ngth

    (bp

    s)

    # SN

    Ps p

    er g

    ene

    # SN

    Ps p

    er g

    ene

    Minimum SNP in Gene Minimum SNP in Gene Gene Length (bps)

  • 1/6/10

    8

    Permutation Analysis shows that Gene Length adjustment performs better than a naïve Gene Scoring

    The resulting Meta-rank prioritizes the Genome according to the Phenotype

    (Hansen,
Lage,
Pers
et
al,
SubmiIed)



Recommended